Scientists have created a cure for premature ejaculation
Last reviewed: 23.04.2024
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Recently, a representative of the American pharmaceutical company Ampio Pharmaceuticals proudly announced the successful completion of the last stage of the clinical trial of Zertane, which provides the ability of a man to have a prolonged sexual intercourse.
So, according to Ampio Pharmaceuticals, the company will soon apply to the relevant European Union regulatory authority with a request to register the drug and allow its sale in the EU countries - for some reason the company does not plan to enter the US market with it for the time being.
"Analysis of the data obtained from the last stage of Zertan's clinical trials showed that the effectiveness of the drug significantly exceeds our even the most optimistic expectations," says a press release from Ampio Pharmaceuticals.
There is no need to take Zertan courses - enough to take one tablet for a while before a romantic meeting.
It remains to mention that Zertan is nothing but tramadol hydrochloride. For this reason, selling it in pharmacies will be exclusively on the prescription of the doctor, since the drug is an opioid narcotic analgesic.
According to some reports, premature ejaculation affects 23% of the male population aged 18 to 75 years.
[